Range
17.1 - 18.1
Vol / Avg.
1.4M/1.6M
Div / Yield
-
52 Wk
15.88 - 54.21
Mkt Cap
2.8B
Payout Ratio
-
Open
17.55
P/E
-
EPS
-0.55
Shares
156.9M
Outstanding
156.9M
Total Float
131.7M
load more
Sector: Health Care.Industry: Biotechnology
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. It's lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma.

Earnings

see more
Q4 2021Est.ActualSurprise
EPS
(EXPECTED)2022-02-24
REV
Q3 2021Est.ActualSurprise
EPS-0.530-0.550 -0.0200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Iovance Biotherapeutics Questions & Anwsers

Q

How do I buy Iovance Biotherapeutics (IOVA) stock?

A

You can purchase shares of Iovance Biotherapeutics (NASDAQ: IOVA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Iovance Biotherapeutics's (IOVA) competitors?

Q

What is the target price for Iovance Biotherapeutics (IOVA) stock?

A

The latest price target for Iovance Biotherapeutics (NASDAQ: IOVA) was reported by HC Wainwright & Co. on November 5, 2021. The analyst firm set a price target for 43.00 expecting IOVA to rise to within 12 months (a possible 144.18% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Iovance Biotherapeutics (IOVA)?

A

The stock price for Iovance Biotherapeutics (NASDAQ: IOVA) is $17.61 last updated Thu Dec 02 2021 21:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Iovance Biotherapeutics (IOVA) pay a dividend?

A

There are no upcoming dividends for Iovance Biotherapeutics.

Q

When is Iovance Biotherapeutics (NASDAQ:IOVA) reporting earnings?

A

Iovance Biotherapeutics’s $Q4 earnings are confirmed for after-market on February 24, 2022.

Q

Is Iovance Biotherapeutics (IOVA) going to split?

A

There is no upcoming split for Iovance Biotherapeutics.

Q

What sector and industry does Iovance Biotherapeutics (IOVA) operate in?

A

Iovance Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.